Sale!

DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the DYRK1A gene, which have been linked to Autosomal Dominant Mental Retardation Type 7. This condition is characterized by intellectual disability and, in some cases, physical abnormalities and developmental delays. The test is crucial for individuals showing symptoms of the disorder or those with a family history, providing essential information for accurate diagnosis and management.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the DYRK1A gene. The results can offer insights into treatment options, management plans, and the risk of passing the condition on to future generations.

The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in the DYRK1A gene. Given the complexity of genetic disorders, the test is a valuable tool for individuals and families seeking answers about Autosomal Dominant Mental Retardation Type 7, providing them with crucial information to navigate the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test

Welcome to DNA Labs UAE, where we offer the DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test. This test is designed to diagnose and provide valuable information for the management of MRD7, a genetic disorder characterized by intellectual disability, developmental delay, and other associated features.

Test Details

The DYRK1A gene is associated with mental retardation, autosomal dominant type 7 (MRD7). NGS (Next Generation Sequencing) genetic testing is used to identify mutations or variations in the DYRK1A gene that may be responsible for the disorder. This advanced and comprehensive method allows for the simultaneous sequencing of multiple genes or even the entire genome.

Test Components and Price

  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA samples, or one drop of blood on an FTA Card.

Report Delivery

Your test results will be delivered within 3 to 4 weeks.

Test Type

This test falls under the category of Neurological Disorders.

Referring Doctor and Test Department

  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MRD7.

Please note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results.

Test Name DYRK1A Gene Mental retardation autosomal dominant type 7 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DYRK1A Gene Mental retardation, autosomal dominant type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DYRK1A Gene Mental retardation, autosomal dominant type 7
Test Details

The DYRK1A gene is associated with mental retardation, autosomal dominant type 7 (MRD7). MRD7 is a genetic disorder characterized by intellectual disability, developmental delay, and other associated features.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous sequencing of multiple genes or even the entire genome. It is a more advanced and comprehensive method compared to traditional sequencing techniques.

In the context of MRD7, NGS genetic testing can be used to identify mutations or variations in the DYRK1A gene that may be responsible for the disorder. This can help with the diagnosis of MRD7 and provide valuable information for genetic counseling and management of the condition.

NGS genetic testing involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the DNA to analyze the genetic code. The data obtained from the sequencing is then analyzed to identify any genetic variations or mutations in the DYRK1A gene.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results.